Margarita Papatheodoridi

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Corrigendum to 'Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort' [JHEP Reports (2026) 19;8(8):101898].

Corrigendum to 'Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort' [JHEP Reports (2026) 19;8(8):101898].

Journal: JHEP reports : innovation in hepatology

Published: September 03, 2026

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management.

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 06, 2026

HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D.

HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D.

Journal: Journal of viral hepatitis

Published: February 23, 2026

Adherence of Greek gastroenterologists to established quality indicators in gastrointestinal endoscopy.

Adherence of Greek gastroenterologists to established quality indicators in gastrointestinal endoscopy.

Journal: Annals of gastroenterology

Published: February 07, 2026

Nucleos(t)ide analogue treatment in hepatitis B: to stop or not to stop?

Nucleos(t)ide analogue treatment in hepatitis B: to stop or not to stop?

Journal: Expert review of anti-infective therapy

Published: January 02, 2026

Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohort.

Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohort.

Journal: Journal of hepatology

Published: November 24, 2025

Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort.

Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort.

Journal: JHEP reports : innovation in hepatology

Published: November 20, 2025

Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort.

Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort.

Journal: JHEP reports : innovation in hepatology

Published: November 20, 2025

Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort.

Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort.

Journal: Journal of hepatology

Published: October 19, 2025

Long-term outcomes of baseline grey-zone patients with HBeAg-negative chronic hepatitis B virus infection.

Long-term outcomes of baseline grey-zone patients with HBeAg-negative chronic hepatitis B virus infection.

Journal: JHEP reports : innovation in hepatology

Published: October 19, 2025

Primary biliary cholangitis. Treatment options in 2025. A narrative review.

Primary biliary cholangitis. Treatment options in 2025. A narrative review.

Journal: Frontiers in immunology

Published: September 04, 2025

Does Fatty Pancreas Matter? Evaluating the Risk of Post-ERCP Pancreatitis in Patients with Pancreatic Steatosis: A Systemic Review and Meta-Analysis.

Does Fatty Pancreas Matter? Evaluating the Risk of Post-ERCP Pancreatitis in Patients with Pancreatic Steatosis: A Systemic Review and Meta-Analysis.

Journal: Digestive diseases and sciences

Published: August 08, 2025

Showing 1-12 of 68

Last Updated: 09/26/2026